SlideShare ist ein Scribd-Unternehmen logo
1 von 4
- Hematopoiesis - http://hematopoiesis.info -



The growth of autologous cord blood use

Posted By Alex On May 30, 2010 @ 12:21 am In clinical trials | 1 Comment



This is a guest post by:



Frances Verter, PhD (Parent’s Guide to Cord Blood Foundation, USA) and J.J. Nietfeld, PhD (Dept.

of Pathology, Univ. Medical Center Utrecht, Netherlands)



The significance of autologous use of cord blood is a matter of constant debate. Therefore, the

growth rates of autologous use versus allogeneic use of cord blood were compared.



Parent’s Guide to Cord Blood Foundation   [1]
                                                (PGCB) maintains the only international database of

children who received autologous treatments with cord blood that was stored in family banks.

Starting in 2005, cord blood infusions have been used for experimental “regenerative medicine”;

treatments where it is hoped that the infusion of cord blood stem cells will help the patient’s body to

repair itself. By the end of 2009, the database had cataloged 211 autologous treatments around the

world; 73% of them took place in 2008 and 2009.




Correction: Because some cases were just presented at the ISCT 2010        [2]
                                                                                 and not included in our

database yet, we estimate that the actual number of autologous treatments by the end of 2009 is at

least 211 + 44 = 255.



We compare the autologous and allogeneic use of cord blood by plotting the cumulative number of
cord blood treatments versus time, for the autologous data from PGCB and the allogeneic data from

the WMDA   [3]
                 . Looking at 2008, the number of autologous treatments is about 100 times lower than

the number of allogeneic treatments. However, the rise in the cumulative number of allogeneic cord

blood use is linear over the last few years, whereas that number for autologous use is rising faster

than exponential.




Forecast of the future comparison of autologous and allogeneic use of cord blood:

Allogeneic use of cord blood among USA children can be predicted based on the actual transplant

rates compiled by CIBMTR      [4]
                                    for 2001-2003. The cumulative probability that a child will receive (not

require) an allogeneic stem cell transplant by age 10 is 0.02% or 1 in 5000. If all allogeneic

transplants used cord blood as the graft source, that would be the maximum rate of use.

(Reference: Nietfeld JJ et al. 2008; Biology Blood Marrow Transplantation 14:316-322          [5]
                                                                                                    )



Autologous use of cord blood among USA children can be estimated based on the prevalence (ie:

cumulative probability) of those indication for which autologous cord blood is currently being used in

clinical trials. For the sake of argument, let us consider only Cerebral Palsy (CP) and Hypoxic-

Ischemic Encephalopathy (HIE): The prevalence of CP among elementary school children (ages

5-10) in the USA is 1 in 300. (Reference: Centers of Disease Control)

If autologous cord blood therapy should prove efficacious for only 12% of children with CP, the

demand for autologous cord blood would still be 1 in 2500, double the 1 in 5000 use of cord blood

for all pediatric allogeneic transplants combined.
Conclusion:

Medical societies or individual physicians who issue opinions on cord blood storage that

ignore the fast growing autologous use of cord blood for mainly regenerative medicine are

not making evidence-based recommendations.



PS: These data were presented at the International Society for Cellular Therapy annual meeting      [6]
                                                                                                          .

Philadelphia, May 23-26, 2010.



How to cite: Verter F, Nietfeld JJ. The growth of cord blood use. Cytotherapy 2010; 12: suppl. 1,

abstract #157


                                                                                                      [7]




Article printed from Hematopoiesis: http://hematopoiesis.info



URL to article: http://hematopoiesis.info/2010/05/30/the-growth-of-autologous-cord-

blood-use/



URLs in this post:



[1] Parent’s Guide to Cord Blood Foundation: http://parentsguidecordblood.org/



[2] ISCT 2010: http://celltherapy2010.com/



[3] WMDA: http://www.worldmarrow.org/



[4] CIBMTR: http://www.cibmtr.org/



[5] Biology Blood Marrow Transplantation 14:316-322:

http://www.bbmt.org/article/S1083-8791%2807%2901168-8/fulltext



[6] International Society for Cellular Therapy annual meeting: http://celltherapy2010.com



[7] Image: http://twitter.com/home/?

status=The+growth+of+autologous+cord+blood+use+http://c6wka.th8.us



                                                                                   Click here to print.
Copyright © 2009 Hematopoiesis. All rights reserved.

Weitere ähnliche Inhalte

Was ist angesagt?

Cell lineage trees and the limiting problem of comprehensive rejuvenation
Cell lineage trees and the limiting problem of comprehensive rejuvenationCell lineage trees and the limiting problem of comprehensive rejuvenation
Cell lineage trees and the limiting problem of comprehensive rejuvenationattilacsordas
 
predicting-readmission-and-leak-rates-following-colectomy-with-red-cell-distr...
predicting-readmission-and-leak-rates-following-colectomy-with-red-cell-distr...predicting-readmission-and-leak-rates-following-colectomy-with-red-cell-distr...
predicting-readmission-and-leak-rates-following-colectomy-with-red-cell-distr...Peertechz Publications
 
Building and mining a heterogeneous biomedical knowledge graph
Building and mining a heterogeneous biomedical knowledge graphBuilding and mining a heterogeneous biomedical knowledge graph
Building and mining a heterogeneous biomedical knowledge graphAndrew Su
 
ABO Incompatible Kidney Transplantation, Michael Casey, MD (W-0007)
ABO Incompatible Kidney Transplantation, Michael Casey, MD (W-0007)ABO Incompatible Kidney Transplantation, Michael Casey, MD (W-0007)
ABO Incompatible Kidney Transplantation, Michael Casey, MD (W-0007)UF Nephrology
 
Lab 9 - Ginkgo Biloba
Lab 9 - Ginkgo Biloba Lab 9 - Ginkgo Biloba
Lab 9 - Ginkgo Biloba Chirag Shah
 
Engineering students’ re... biomedical conferences
Engineering students’ re... biomedical conferencesEngineering students’ re... biomedical conferences
Engineering students’ re... biomedical conferencesGirish Pathangey
 
ISSCR Human Egg for SC Research Guidelines
ISSCR Human Egg for SC Research GuidelinesISSCR Human Egg for SC Research Guidelines
ISSCR Human Egg for SC Research Guidelinesms emporda
 
ABO incompatible kidney transplantation review
ABO incompatible kidney transplantation reviewABO incompatible kidney transplantation review
ABO incompatible kidney transplantation reviewMaarten Naesens
 

Was ist angesagt? (12)

Identifying new biomarkers
Identifying new biomarkersIdentifying new biomarkers
Identifying new biomarkers
 
Kritharides
KritharidesKritharides
Kritharides
 
Cell lineage trees and the limiting problem of comprehensive rejuvenation
Cell lineage trees and the limiting problem of comprehensive rejuvenationCell lineage trees and the limiting problem of comprehensive rejuvenation
Cell lineage trees and the limiting problem of comprehensive rejuvenation
 
predicting-readmission-and-leak-rates-following-colectomy-with-red-cell-distr...
predicting-readmission-and-leak-rates-following-colectomy-with-red-cell-distr...predicting-readmission-and-leak-rates-following-colectomy-with-red-cell-distr...
predicting-readmission-and-leak-rates-following-colectomy-with-red-cell-distr...
 
White Paper 2012
White Paper 2012White Paper 2012
White Paper 2012
 
Building and mining a heterogeneous biomedical knowledge graph
Building and mining a heterogeneous biomedical knowledge graphBuilding and mining a heterogeneous biomedical knowledge graph
Building and mining a heterogeneous biomedical knowledge graph
 
ABO Incompatible Kidney Transplantation, Michael Casey, MD (W-0007)
ABO Incompatible Kidney Transplantation, Michael Casey, MD (W-0007)ABO Incompatible Kidney Transplantation, Michael Casey, MD (W-0007)
ABO Incompatible Kidney Transplantation, Michael Casey, MD (W-0007)
 
Lab 9 - Ginkgo Biloba
Lab 9 - Ginkgo Biloba Lab 9 - Ginkgo Biloba
Lab 9 - Ginkgo Biloba
 
Engineering students’ re... biomedical conferences
Engineering students’ re... biomedical conferencesEngineering students’ re... biomedical conferences
Engineering students’ re... biomedical conferences
 
ISSCR Human Egg for SC Research Guidelines
ISSCR Human Egg for SC Research GuidelinesISSCR Human Egg for SC Research Guidelines
ISSCR Human Egg for SC Research Guidelines
 
STEM CELL THERAPY
STEM CELL THERAPYSTEM CELL THERAPY
STEM CELL THERAPY
 
ABO incompatible kidney transplantation review
ABO incompatible kidney transplantation reviewABO incompatible kidney transplantation review
ABO incompatible kidney transplantation review
 

Ähnlich wie The usage trend of autologous stem cell

Cells4 life latest clinical updates for stem cell therapies
Cells4 life   latest clinical updates for stem cell therapiesCells4 life   latest clinical updates for stem cell therapies
Cells4 life latest clinical updates for stem cell therapiesCells4Life Middle East
 
Cord banks worth of investment.pdf
Cord banks worth of investment.pdfCord banks worth of investment.pdf
Cord banks worth of investment.pdfsohal
 
CellTherapyTrends10
CellTherapyTrends10CellTherapyTrends10
CellTherapyTrends10nanog
 
Stem-cell therapy in medicine–how far we came and what we can expect?
Stem-cell therapy in medicine–how far we came and what we can expect?Stem-cell therapy in medicine–how far we came and what we can expect?
Stem-cell therapy in medicine–how far we came and what we can expect?Apollo Hospitals
 
Stem Cell Research: Trends and Perspectives on the Evolving International Lan...
Stem Cell Research: Trends and Perspectives on the Evolving International Lan...Stem Cell Research: Trends and Perspectives on the Evolving International Lan...
Stem Cell Research: Trends and Perspectives on the Evolving International Lan...Elsevier
 
Plasma for fractionation and Patient Blood Management.
Plasma for fractionation and Patient Blood Management.Plasma for fractionation and Patient Blood Management.
Plasma for fractionation and Patient Blood Management.Albert Farrugia
 
When matched family donor is not available for blood and marrow transplantati...
When matched family donor is not available for blood and marrow transplantati...When matched family donor is not available for blood and marrow transplantati...
When matched family donor is not available for blood and marrow transplantati...Apollo Hospitals
 
Ch 24 _clinical_trials_and_family_banking_of_perinatal_stem_cells
Ch 24 _clinical_trials_and_family_banking_of_perinatal_stem_cellsCh 24 _clinical_trials_and_family_banking_of_perinatal_stem_cells
Ch 24 _clinical_trials_and_family_banking_of_perinatal_stem_cellsComprehensiveBiologi
 
Elma mg jurnal mobilisasi
Elma mg jurnal mobilisasiElma mg jurnal mobilisasi
Elma mg jurnal mobilisasiMaharaniElma
 
Reducing variation in hospital admissions from the emergency department for l...
Reducing variation in hospital admissions from the emergency department for l...Reducing variation in hospital admissions from the emergency department for l...
Reducing variation in hospital admissions from the emergency department for l...John Frias Morales, DrBA, MS
 
A Paradigm Shift in the Utilization of Therapeutic Plasmapheresis in Clinical...
A Paradigm Shift in the Utilization of Therapeutic Plasmapheresis in Clinical...A Paradigm Shift in the Utilization of Therapeutic Plasmapheresis in Clinical...
A Paradigm Shift in the Utilization of Therapeutic Plasmapheresis in Clinical...semualkaira
 
A Paradigm Shift in the Utilization of Therapeutic Plasmapheresis in Clinical...
A Paradigm Shift in the Utilization of Therapeutic Plasmapheresis in Clinical...A Paradigm Shift in the Utilization of Therapeutic Plasmapheresis in Clinical...
A Paradigm Shift in the Utilization of Therapeutic Plasmapheresis in Clinical...semualkaira
 
Provision of ideal transfusion support – The essence of thalassemia care
Provision of ideal transfusion support – The essence of thalassemia careProvision of ideal transfusion support – The essence of thalassemia care
Provision of ideal transfusion support – The essence of thalassemia careApollo Hospitals
 
Insights and Hopes in Umbilical Cord Blood Stem Cell Transplantations
Insights and Hopes in Umbilical Cord Blood Stem Cell TransplantationsInsights and Hopes in Umbilical Cord Blood Stem Cell Transplantations
Insights and Hopes in Umbilical Cord Blood Stem Cell TransplantationsAnkita-rastogi
 
Modeling Time to Death of HIV Infected Patients on Antiretroviral Therapy in ...
Modeling Time to Death of HIV Infected Patients on Antiretroviral Therapy in ...Modeling Time to Death of HIV Infected Patients on Antiretroviral Therapy in ...
Modeling Time to Death of HIV Infected Patients on Antiretroviral Therapy in ...Premier Publishers
 
FIBRILACION AURICULAR EN URGENCIAS THE After Study
FIBRILACION AURICULAR EN URGENCIAS  THE After StudyFIBRILACION AURICULAR EN URGENCIAS  THE After Study
FIBRILACION AURICULAR EN URGENCIAS THE After Studyjasar
 
Dynamics of Combined Oral Contraceptive: A Study of Some Haematological Param...
Dynamics of Combined Oral Contraceptive: A Study of Some Haematological Param...Dynamics of Combined Oral Contraceptive: A Study of Some Haematological Param...
Dynamics of Combined Oral Contraceptive: A Study of Some Haematological Param...iosrphr_editor
 

Ähnlich wie The usage trend of autologous stem cell (20)

Cells4 life latest clinical updates for stem cell therapies
Cells4 life   latest clinical updates for stem cell therapiesCells4 life   latest clinical updates for stem cell therapies
Cells4 life latest clinical updates for stem cell therapies
 
Cord banks worth of investment.pdf
Cord banks worth of investment.pdfCord banks worth of investment.pdf
Cord banks worth of investment.pdf
 
CellTherapyTrends10
CellTherapyTrends10CellTherapyTrends10
CellTherapyTrends10
 
Stem-cell therapy in medicine–how far we came and what we can expect?
Stem-cell therapy in medicine–how far we came and what we can expect?Stem-cell therapy in medicine–how far we came and what we can expect?
Stem-cell therapy in medicine–how far we came and what we can expect?
 
Stem Cell Research: Trends and Perspectives on the Evolving International Lan...
Stem Cell Research: Trends and Perspectives on the Evolving International Lan...Stem Cell Research: Trends and Perspectives on the Evolving International Lan...
Stem Cell Research: Trends and Perspectives on the Evolving International Lan...
 
Plasma for fractionation and Patient Blood Management.
Plasma for fractionation and Patient Blood Management.Plasma for fractionation and Patient Blood Management.
Plasma for fractionation and Patient Blood Management.
 
When matched family donor is not available for blood and marrow transplantati...
When matched family donor is not available for blood and marrow transplantati...When matched family donor is not available for blood and marrow transplantati...
When matched family donor is not available for blood and marrow transplantati...
 
Ch 24 _clinical_trials_and_family_banking_of_perinatal_stem_cells
Ch 24 _clinical_trials_and_family_banking_of_perinatal_stem_cellsCh 24 _clinical_trials_and_family_banking_of_perinatal_stem_cells
Ch 24 _clinical_trials_and_family_banking_of_perinatal_stem_cells
 
Elma mg jurnal mobilisasi
Elma mg jurnal mobilisasiElma mg jurnal mobilisasi
Elma mg jurnal mobilisasi
 
Where Does Blood Go? Study on Transfusion Practices in SAQR Hospital, Ras Al ...
Where Does Blood Go? Study on Transfusion Practices in SAQR Hospital, Ras Al ...Where Does Blood Go? Study on Transfusion Practices in SAQR Hospital, Ras Al ...
Where Does Blood Go? Study on Transfusion Practices in SAQR Hospital, Ras Al ...
 
Reducing variation in hospital admissions from the emergency department for l...
Reducing variation in hospital admissions from the emergency department for l...Reducing variation in hospital admissions from the emergency department for l...
Reducing variation in hospital admissions from the emergency department for l...
 
A Paradigm Shift in the Utilization of Therapeutic Plasmapheresis in Clinical...
A Paradigm Shift in the Utilization of Therapeutic Plasmapheresis in Clinical...A Paradigm Shift in the Utilization of Therapeutic Plasmapheresis in Clinical...
A Paradigm Shift in the Utilization of Therapeutic Plasmapheresis in Clinical...
 
A Paradigm Shift in the Utilization of Therapeutic Plasmapheresis in Clinical...
A Paradigm Shift in the Utilization of Therapeutic Plasmapheresis in Clinical...A Paradigm Shift in the Utilization of Therapeutic Plasmapheresis in Clinical...
A Paradigm Shift in the Utilization of Therapeutic Plasmapheresis in Clinical...
 
Provision of ideal transfusion support – The essence of thalassemia care
Provision of ideal transfusion support – The essence of thalassemia careProvision of ideal transfusion support – The essence of thalassemia care
Provision of ideal transfusion support – The essence of thalassemia care
 
Insights and Hopes in Umbilical Cord Blood Stem Cell Transplantations
Insights and Hopes in Umbilical Cord Blood Stem Cell TransplantationsInsights and Hopes in Umbilical Cord Blood Stem Cell Transplantations
Insights and Hopes in Umbilical Cord Blood Stem Cell Transplantations
 
Effect of sex_hormones _and _prolactin_on _sickle_cell_ erythrocyte_polymeris...
Effect of sex_hormones _and _prolactin_on _sickle_cell_ erythrocyte_polymeris...Effect of sex_hormones _and _prolactin_on _sickle_cell_ erythrocyte_polymeris...
Effect of sex_hormones _and _prolactin_on _sickle_cell_ erythrocyte_polymeris...
 
Modeling Time to Death of HIV Infected Patients on Antiretroviral Therapy in ...
Modeling Time to Death of HIV Infected Patients on Antiretroviral Therapy in ...Modeling Time to Death of HIV Infected Patients on Antiretroviral Therapy in ...
Modeling Time to Death of HIV Infected Patients on Antiretroviral Therapy in ...
 
Techno-borne organs (by Naira Matevosyan)
Techno-borne organs (by Naira Matevosyan)Techno-borne organs (by Naira Matevosyan)
Techno-borne organs (by Naira Matevosyan)
 
FIBRILACION AURICULAR EN URGENCIAS THE After Study
FIBRILACION AURICULAR EN URGENCIAS  THE After StudyFIBRILACION AURICULAR EN URGENCIAS  THE After Study
FIBRILACION AURICULAR EN URGENCIAS THE After Study
 
Dynamics of Combined Oral Contraceptive: A Study of Some Haematological Param...
Dynamics of Combined Oral Contraceptive: A Study of Some Haematological Param...Dynamics of Combined Oral Contraceptive: A Study of Some Haematological Param...
Dynamics of Combined Oral Contraceptive: A Study of Some Haematological Param...
 

Mehr von michelle129wang

First fda approval of cb drug
First fda approval of cb drugFirst fda approval of cb drug
First fda approval of cb drugmichelle129wang
 
Combined private and public banking of cord blood and other rlated products
Combined private and public banking of cord blood and other rlated productsCombined private and public banking of cord blood and other rlated products
Combined private and public banking of cord blood and other rlated productsmichelle129wang
 
Thermogenesis 2010 annual report
Thermogenesis 2010 annual reportThermogenesis 2010 annual report
Thermogenesis 2010 annual reportmichelle129wang
 

Mehr von michelle129wang (6)

First fda approval of cb drug
First fda approval of cb drugFirst fda approval of cb drug
First fda approval of cb drug
 
Combined private and public banking of cord blood and other rlated products
Combined private and public banking of cord blood and other rlated productsCombined private and public banking of cord blood and other rlated products
Combined private and public banking of cord blood and other rlated products
 
周產期180 1
周產期180 1周產期180 1
周產期180 1
 
Leaf diary
Leaf diaryLeaf diary
Leaf diary
 
2011
20112011
2011
 
Thermogenesis 2010 annual report
Thermogenesis 2010 annual reportThermogenesis 2010 annual report
Thermogenesis 2010 annual report
 

Kürzlich hochgeladen

SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfSanaAli374401
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Celine George
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingTeacherCyreneCayanan
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docxPoojaSen20
 
psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docxPoojaSen20
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfagholdier
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfJayanti Pande
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterMateoGardella
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxVishalSingh1417
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxAreebaZafar22
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfChris Hunter
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfAyushMahapatra5
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxVishalSingh1417
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104misteraugie
 

Kürzlich hochgeladen (20)

SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdf
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writing
 
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docx
 
psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docx
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch Letter
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdf
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 

The usage trend of autologous stem cell

  • 1. - Hematopoiesis - http://hematopoiesis.info - The growth of autologous cord blood use Posted By Alex On May 30, 2010 @ 12:21 am In clinical trials | 1 Comment This is a guest post by: Frances Verter, PhD (Parent’s Guide to Cord Blood Foundation, USA) and J.J. Nietfeld, PhD (Dept. of Pathology, Univ. Medical Center Utrecht, Netherlands) The significance of autologous use of cord blood is a matter of constant debate. Therefore, the growth rates of autologous use versus allogeneic use of cord blood were compared. Parent’s Guide to Cord Blood Foundation [1] (PGCB) maintains the only international database of children who received autologous treatments with cord blood that was stored in family banks. Starting in 2005, cord blood infusions have been used for experimental “regenerative medicine”; treatments where it is hoped that the infusion of cord blood stem cells will help the patient’s body to repair itself. By the end of 2009, the database had cataloged 211 autologous treatments around the world; 73% of them took place in 2008 and 2009. Correction: Because some cases were just presented at the ISCT 2010 [2] and not included in our database yet, we estimate that the actual number of autologous treatments by the end of 2009 is at least 211 + 44 = 255. We compare the autologous and allogeneic use of cord blood by plotting the cumulative number of
  • 2. cord blood treatments versus time, for the autologous data from PGCB and the allogeneic data from the WMDA [3] . Looking at 2008, the number of autologous treatments is about 100 times lower than the number of allogeneic treatments. However, the rise in the cumulative number of allogeneic cord blood use is linear over the last few years, whereas that number for autologous use is rising faster than exponential. Forecast of the future comparison of autologous and allogeneic use of cord blood: Allogeneic use of cord blood among USA children can be predicted based on the actual transplant rates compiled by CIBMTR [4] for 2001-2003. The cumulative probability that a child will receive (not require) an allogeneic stem cell transplant by age 10 is 0.02% or 1 in 5000. If all allogeneic transplants used cord blood as the graft source, that would be the maximum rate of use. (Reference: Nietfeld JJ et al. 2008; Biology Blood Marrow Transplantation 14:316-322 [5] ) Autologous use of cord blood among USA children can be estimated based on the prevalence (ie: cumulative probability) of those indication for which autologous cord blood is currently being used in clinical trials. For the sake of argument, let us consider only Cerebral Palsy (CP) and Hypoxic- Ischemic Encephalopathy (HIE): The prevalence of CP among elementary school children (ages 5-10) in the USA is 1 in 300. (Reference: Centers of Disease Control) If autologous cord blood therapy should prove efficacious for only 12% of children with CP, the demand for autologous cord blood would still be 1 in 2500, double the 1 in 5000 use of cord blood for all pediatric allogeneic transplants combined.
  • 3. Conclusion: Medical societies or individual physicians who issue opinions on cord blood storage that ignore the fast growing autologous use of cord blood for mainly regenerative medicine are not making evidence-based recommendations. PS: These data were presented at the International Society for Cellular Therapy annual meeting [6] . Philadelphia, May 23-26, 2010. How to cite: Verter F, Nietfeld JJ. The growth of cord blood use. Cytotherapy 2010; 12: suppl. 1, abstract #157 [7] Article printed from Hematopoiesis: http://hematopoiesis.info URL to article: http://hematopoiesis.info/2010/05/30/the-growth-of-autologous-cord- blood-use/ URLs in this post: [1] Parent’s Guide to Cord Blood Foundation: http://parentsguidecordblood.org/ [2] ISCT 2010: http://celltherapy2010.com/ [3] WMDA: http://www.worldmarrow.org/ [4] CIBMTR: http://www.cibmtr.org/ [5] Biology Blood Marrow Transplantation 14:316-322: http://www.bbmt.org/article/S1083-8791%2807%2901168-8/fulltext [6] International Society for Cellular Therapy annual meeting: http://celltherapy2010.com [7] Image: http://twitter.com/home/? status=The+growth+of+autologous+cord+blood+use+http://c6wka.th8.us Click here to print.
  • 4. Copyright © 2009 Hematopoiesis. All rights reserved.